全文获取类型
收费全文 | 3073篇 |
免费 | 173篇 |
国内免费 | 12篇 |
专业分类
耳鼻咽喉 | 18篇 |
儿科学 | 64篇 |
妇产科学 | 64篇 |
基础医学 | 463篇 |
口腔科学 | 58篇 |
临床医学 | 231篇 |
内科学 | 888篇 |
皮肤病学 | 82篇 |
神经病学 | 277篇 |
特种医学 | 37篇 |
外科学 | 261篇 |
综合类 | 17篇 |
预防医学 | 279篇 |
眼科学 | 34篇 |
药学 | 210篇 |
中国医学 | 14篇 |
肿瘤学 | 261篇 |
出版年
2023年 | 29篇 |
2022年 | 52篇 |
2021年 | 108篇 |
2020年 | 65篇 |
2019年 | 88篇 |
2018年 | 95篇 |
2017年 | 73篇 |
2016年 | 76篇 |
2015年 | 95篇 |
2014年 | 119篇 |
2013年 | 160篇 |
2012年 | 211篇 |
2011年 | 263篇 |
2010年 | 127篇 |
2009年 | 133篇 |
2008年 | 223篇 |
2007年 | 221篇 |
2006年 | 206篇 |
2005年 | 204篇 |
2004年 | 177篇 |
2003年 | 163篇 |
2002年 | 152篇 |
2001年 | 17篇 |
2000年 | 5篇 |
1999年 | 14篇 |
1998年 | 20篇 |
1997年 | 15篇 |
1996年 | 19篇 |
1995年 | 15篇 |
1994年 | 15篇 |
1993年 | 5篇 |
1992年 | 9篇 |
1991年 | 6篇 |
1990年 | 4篇 |
1989年 | 6篇 |
1983年 | 3篇 |
1982年 | 5篇 |
1980年 | 3篇 |
1978年 | 3篇 |
1977年 | 3篇 |
1976年 | 3篇 |
1974年 | 3篇 |
1973年 | 3篇 |
1966年 | 2篇 |
1961年 | 2篇 |
1941年 | 3篇 |
1940年 | 3篇 |
1938年 | 2篇 |
1934年 | 2篇 |
1918年 | 2篇 |
排序方式: 共有3258条查询结果,搜索用时 15 毫秒
101.
Littera R Orrù N Caocci G Sanna M Mulargia M Piras E Vacca A Giardini C Orofino MG Visani G Bertaina A Giorgiani G Locatelli F Carcassi C La Nasa G 《British journal of haematology》2012,156(1):118-128
In a study conducted on 114 patients undergoing unrelated donor haematopoietic stem cell transplantation (HSCT) for thalassaemia, we observed that the lack of activating killer immunoglobulin-like receptors (KIRs) on donor natural killer (NK) cells significantly increased the risk of graft-versus-host disease (GvHD) [hazard risk (HR) 4.2, 95% confidence interval (CI) 1.7-10.1, P = 0.002] and transplantation-related mortality (HR 4.7, 95% CI 1.6-14.2, P = 0.01). The risk of GvHD furthermore increased when recipients heterozygous for HLA-C KIR ligand groups (C1/C2) were transplanted from donors completely lacking activating KIRs (HR 6.1, 95% CI 1.9-19.2, P = 0.002). We also found that the risk of rejection was highest when the recipient was homozygous for the C2 HLA-KIR ligand group and the donor carried two or more activating KIRs (HR 6.8, 95% CI 1.9-24.4, P = 0.005). By interpolating the number of donor activating KIRs with recipient HLA-C KIR ligands, we created an algorithm capable of stratifying patients according to the immunogenetic risk of complications following unrelated HSCT. In clinical practice, this predictive tool could serve as an important supplement to clinical judgement and decision-making. 相似文献
102.
103.
104.
Progression to cirrhosis occurs faster whereas response to peginterferon/ribavirin therapy is lower in patients with chronic hepatitis C coinfected with human immunodeficiency virus (HIV), as compared with hepatitis C virus (HCV) monoinfected individuals. The use of antiretroviral therapy may ameliorate poor outcomes in HIV/HCV coinfected patients. However, in the best scenario peginterferon/ribavirin therapy provides cure to 30% of patients harboring HCV genotypes 1 or 4 and to 70% of HCV genotypes 2 or 3 carriers, a rate lower than that seen in HCV monoinfection. Moreover, a substantial proportion of HIV/HCV coinfected patients are not treated due to contraindications, or do not complete therapy due to serious adverse events, or just do not wish to receive such a poorly tolerated medication. For these reasons, the advent of direct acting antivirals (DAA) has been eagerly awaited for treating HIV/HCV coinfected patients. However, new challenges have arisen, including the potential for harmful drug interactions with antiretroviral agents, poor drug adherence due to polymedication, increased risk for selection of drug-resistant HCV mutants, and unaffordable coverage in an environment of economic constraints. The use of noninvasive tools to measure liver fibrosis (i.e., elastometry) and pharmacogenomics (testing for IL28B and perhaps ITPA polymorphisms), along with consideration of early viral kinetics to guide length and drugs needed could help to individualize and improve the cost effectiveness of therapeutic decisions using DAA in HIV-infected patients with chronic hepatitis C. 相似文献
105.
López-Corral L Mateos MV Corchete LA Sarasquete ME de la Rubia J de Arriba F Lahuerta JJ García-Sanz R San Miguel JF Gutiérrez NC 《Haematologica》2012,97(9):1439-1443
Smoldering myeloma is an asymptomatic plasma cell dyscrasia with a heterogeneous propensity to progress to active myeloma. In order to investigate the biology of smoldering myeloma patients with high risk of progression, we analyzed the genomic characteristics by FISH, SNP-arrays and gene expression profile of a group of patients with high-risk smoldering myeloma included in a multicenter randomized trial. Chromosomal abnormalities detected by FISH and SNP-arrays at diagnosis were not associated to risk of progression to symptomatic myeloma. However, the overexpression of four SNORD genes (SNORD25, SNORD27, SNORD30 and SNORD31) was correlated with shorter time to progression (P<0.03). When plasma cells from high-risk smoldering patients who progressed to symptomatic myeloma were sequentially analyzed, newly acquired lesions together with an increase in the proportion of plasma cells carrying a given abnormality were observed. These findings suggest that gene expression profiling is a valuable technique to identify smoldering myeloma patients with high risk of progression. (Clinical Trials NCT00443235). 相似文献
106.
Maarten J Titulaer Lindsey McCracken Iñigo Gabilondo Thaís Armangué Carol Glaser Takahiro Iizuka Lawrence S Honig Susanne M Benseler Izumi Kawachi Eugenia Martinez-Hernandez Esther Aguilar Núria Gresa-Arribas Nicole Ryan-Florance Abiguei Torrents Albert Saiz Myrna R Rosenfeld Rita Balice-Gordon Francesc Graus Josep Dalmau 《Lancet neurology》2013,12(2):157-165
107.
Eugenia Borgione Mariangela Lo Giudice Filippa Castello Sebastiano A. Musumeci Francesco D. Di Blasi Maria Savio Maurizio Elia Biagio Rizzo Giuliano Barbarino Salvatore Romano Giuseppe Calabrese Daniela Di Benedetto Carmela Scuderi 《Neurological sciences》2013,34(7):1223-1226
A deletion of one of the two copies of the 9-bp tandem repeat sequence (CCCCCTCTA), in the small non-coding/untranslated segment located between the cytochrome oxidase II and lysine tRNA genes of mitochondrial DNA (mtDNA), has previously been used as a polymorphic anthropological marker (MIC9D) for people of Africa and Asia, but it has been rarely reported in Europe. 32 Sicilian patients with syndromic hearing loss, negative for mutations in GJB2 and GJB6 genes, were tested for mtDNA known point mutations associated with syndromic or non-syndromic hearing loss by RFLP and/or direct sequencing. We identified the presence of the MIC9D in homoplasmy in lymphocytes and muscle of three subjects with sensorineural hearing loss and encephalomyopathy, two of these also presented moderate mental retardation. This deletion was absent in 300 Caucasian controls. Although further studies are warranted, our results suggest that the MIC9D polymorphism could have a susceptibility role in Caucasus, such as Sicily population. 相似文献
108.
Amalia Vartanian Galina Gatsina Irina Grigorieva Elico Solomko Vladislav Dombrovsky Anatoly Baryshnikov Eugenia Stepanova 《Clinical and experimental medicine》2013,13(3):201-209
Notch signaling plays an important role in tumor angiogenesis. Recent studies suggest that Notch signaling also regulates the progression of primary melanomas toward an aggressive phenotype. The aim of this study was to investigate the involvement of Notch signaling pathway in organization of tumor cells into capillary-like structures (CLS), the phenomenon also known as vasculogenic mimicry (VM). Here, we show that Notch signaling cascade was constitutively active in melanoma cell lines we used. Blocking Notch signaling with the γ-secretase inhibitors, DAPT, dibenzazepine or Jagged1 neutralizing antibody resulted in stabilization of CLS indicating that Notch signaling pathway attenuates melanoma VM. We further studied this phenomenon on melanomas grafted in nude mice. Compared to control, VM channels in DAPT-treated grafted melanoma became larger and more branched. DAPT-treated melanomas also exhibited an up-regulation of MMP-2 and VEGFR1, both known as VM mediators. Moreover, we did not observe necrosis in VM channels areas of DAPT-treated melanomas. These findings indicate that VM regulated by Notch signaling may present a novel target in melanoma therapy. 相似文献
109.
Rasche L Bernard C Topp MS Kapp M Duell J Wesemeier C Haralambieva E Maeder U Einsele H Knop S 《Annals of hematology》2012,91(7):1031-1037
Extramedullary (e) relapse in multiple myeloma(MM) has an adverse prognosis, but knowledge concerning biological features and preferred treatment is scarce. We screened the myeloma registry of our institution for eMM relapses and identified 24 cases among 357 patients (pts).Only 8% of eMM relapses occurred after initial therapy, but 54% occurred after third-line or subsequent therapy. Baseline molecular cytogenetics revealed high-risk features in 10 of 19 evaluable patients. Most frequently, eMM presented as soft tissue (67%) and organ involvement (25%) or malignant effusion (12.5%). Incidence of leptomeningeal/CNS involvement was 21%. At eMM relapse, bone marrow infiltration was absent in 46% and low in 21%. Ten eMM biopsies were available showing increased proliferation, i.e., Ki-67 of 67%(range, 30–90%) of all cancer cells. Pts received radiation therapy, dose-intense chemotherapy, novel agents, and allogeneic SCT resulting in an overall response rate of 54%. Median progression-free survival was 2 (95% CI 0.08–3.92) and median overall survival 7 months (95% CI 3.56–10.43), respectively,with only three patients being alive at 12 months from diagnosis. EMM relapse may present at any anatomical site with frequent CNS involvement. Biological features include increased proliferation and low rate of marrow involvement.Prognosis remains poor despite intensive treatment. 相似文献
110.